Yasuko Kato Selected Research

FR 171113

7/2003

Inhibition of arterial thrombosis by a protease-activated receptor 1 antagonist, FR171113, in the guinea pig.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuko Kato Research Topics

Disease

3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2013 - 01/2012
3	Anaphylaxis (Anaphylactic Shock) 01/2011 - 12/2005
3	Exercise-Induced Allergies 01/2011 - 01/2006
2	Thrombosis (Thrombus) 07/2013 - 07/2003
2	Pathologic Constriction (Stenosis) 01/2011 - 10/2009
1	Bone Resorption 06/2022
1	Osteoporosis 06/2022
1	Myocardial Infarction 07/2019
1	Wounds and Injuries (Trauma) 01/2019
1	Chromosome Inversion (Chromosomal Inversion) 01/2018
1	Hyperemia 01/2017
1	Ventricular Tachycardia 01/2017
1	Coronary Disease (Coronary Heart Disease) 01/2017
1	Complementation Group D1 Fanconi Anemia 10/2016
1	Fanconi Anemia (Fanconi's Anemia) 10/2016
1	Ulcer 07/2013
1	Stomach Ulcer (Gastric Ulcer) 07/2013
1	Hyperaldosteronism (Conn Syndrome) 12/2012
1	Heart Failure 01/2012
1	Virus Diseases (Viral Diseases) 11/2010
1	Hyperplasia 10/2009
1	Infections 03/2008
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2008
1	Experimental Arthritis 12/2005
1	Arthritis (Polyarthritis) 12/2005
1	Hypersensitivity (Allergy) 12/2005
1	Contact Dermatitis (Eczema, Contact) 12/2005
1	Urticaria (Hives) 12/2005
1	Carotid Artery Thrombosis 07/2003

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2006
3	GliadinIBA 01/2011 - 01/2006
2	PapaverineIBA 01/2017 - 01/2017
2	Immunoglobulin E (IgE)IBA 01/2011 - 06/2008
2	AllergensIBA 01/2011 - 01/2011
1	tartaric acid (tartrate)FDA Link 06/2022
1	deoxypyridinolineIBA 06/2022
1	AcidsIBA 06/2022
1	Prednisolone (Predate)FDA LinkGeneric 06/2022
1	Radioisotopes (Radionuclides)IBA 01/2018
1	Adenosine (Adenocard)FDA LinkGeneric 01/2017
1	Adenosine Triphosphate (ATP)IBA 01/2017
1	Contrast MediaIBA 01/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	Discoidin Domain ReceptorsIBA 10/2016
1	3- methoxy- 1,5- bis(4- methoxyphenyl)- 1H- 1,2,4- triazoleIBA 07/2013
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2013
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2013
1	aliskiren FDA Link 01/2013
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2013
1	LipidsIBA 01/2013
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2013
1	LDL CholesterolIBA 01/2013
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2013
1	Angiotensin II Type 1 Receptor BlockersIBA 01/2013
1	PotassiumIBA 12/2012
1	Eicosapentaenoic AcidIBA 01/2012
1	Sirolimus (Rapamycin)FDA Link 01/2011
1	LigandsIBA 11/2010
1	InterferonsIBA 11/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2010
1	resiquimodIBA 11/2010
1	Proteoglycans (Proteoglycan)IBA 10/2009
1	Toll-Like Receptor 4IBA 06/2008
1	Immunoglobulin G (IgG)IBA 06/2008
1	LipopolysaccharidesIBA 06/2008
1	Histamine (Histamine Dihydrochloride)FDA Link 06/2008
1	Poly I-CIBA 03/2008
1	omega-Chloroacetophenone (Mace)IBA 01/2008
1	gluteninIBA 01/2006
1	Excitatory Amino AcidsIBA 12/2005
1	CytokinesIBA 12/2005
1	Collagen Type II (Type II Collagen)IBA 12/2005
1	Glutamic Acid (Glutamate)FDA Link 12/2005
1	Neurotransmitter Agents (Neurotransmitter)IBA 12/2005
1	Messenger RNA (mRNA)IBA 12/2005
1	ChitosanIBA 12/2005
1	ChitinIBA 12/2005
1	PAR-1 ReceptorIBA 07/2003
1	FR 171113IBA 07/2003

Therapy/Procedure

2	Therapeutics 01/2019 - 01/2013
2	Stents 01/2011 - 10/2009
1	Oral Administration 06/2022
1	Renal Replacement Therapy (Therapies, Renal Replacement) 07/2019
1	Nuclear Power Plants 01/2018
1	Intra-Aortic Balloon Pumping 01/2012
1	Percutaneous Coronary Intervention 01/2011
1	Aftercare (After-Treatment) 11/2010